OBJECTIVE: To estimate the smallest decrease in Headache Impact Test (HIT) scores that reflects meaningful clinical change among patients with chronic daily headache (CDH). STUDY DESIGN AND SETTING: We applied four methods of estimating the minimum important difference (MID) to data from 71 patients with CDH who participated in a clinical trial. The HIT was administered at baseline and at the 6-week follow-up assessment. Patients were considered to have experienced meaningful improvement if they reported that their headache condition was "somewhat better" or "much better" at the 6-week follow-up. RESULTS:Mean HIT scores at baseline and 6 weeks for all patients were 64.5 (standard deviation SD = 6.0) and 62.6 (SD = 5.7), respectively. HIT scores decreased 3.7 (SD = 4.4) and 1.4 (SD = 3.6) units, respectively, among patients who reported "somewhat better" change and those who reported no change at 6 weeks. Estimates of the MID of the HIT ranged from -2.7 to -2.3. CONCLUSIONS: The method that we judge to be most valid estimated the MID of the HIT at -2.3 units (95% confidence interval = -4.3, -0.3). This suggests that a between-group difference in HIT change scores of 2.3 units over time among patients with CDH reflects improvement in patients' headache condition that may be considered clinically significant.
RCT Entities:
OBJECTIVE: To estimate the smallest decrease in Headache Impact Test (HIT) scores that reflects meaningful clinical change among patients with chronic daily headache (CDH). STUDY DESIGN AND SETTING: We applied four methods of estimating the minimum important difference (MID) to data from 71 patients with CDH who participated in a clinical trial. The HIT was administered at baseline and at the 6-week follow-up assessment. Patients were considered to have experienced meaningful improvement if they reported that their headache condition was "somewhat better" or "much better" at the 6-week follow-up. RESULTS: Mean HIT scores at baseline and 6 weeks for all patients were 64.5 (standard deviation SD = 6.0) and 62.6 (SD = 5.7), respectively. HIT scores decreased 3.7 (SD = 4.4) and 1.4 (SD = 3.6) units, respectively, among patients who reported "somewhat better" change and those who reported no change at 6 weeks. Estimates of the MID of the HIT ranged from -2.7 to -2.3. CONCLUSIONS: The method that we judge to be most valid estimated the MID of the HIT at -2.3 units (95% confidence interval = -4.3, -0.3). This suggests that a between-group difference in HIT change scores of 2.3 units over time among patients with CDH reflects improvement in patients' headache condition that may be considered clinically significant.
Authors: Philip A Cook; Thomas M Johnson; Suzanne G Martin; Philip R Gehrman; Seema Bhatnagar; James C Gee Journal: J Neurotrauma Date: 2018-03-01 Impact factor: 5.269
Authors: Benjamin W Friedman; Clemencia Solorzano; Jennifer Norton; Victoria Adewumni; Caron M Campbell; David Esses; Polly E Bijur; Seymour Solomon; Richard B Lipton; E John Gallagher Journal: Acad Emerg Med Date: 2012-09-20 Impact factor: 3.451
Authors: Antonia F H Smelt; Jeanet W Blom; Frans Dekker; M Elske van den Akker; Arie Knuistingh Neven; Frans G Zitman; Michel D Ferrari; Pim Assendelft Journal: CMAJ Date: 2012-01-09 Impact factor: 8.262
Authors: Ravishankar Jayadevappa; Stanley Bruce Malkowicz; Marsha Wittink; Alan J Wein; Sumedha Chhatre Journal: Health Serv Res Date: 2012-03-14 Impact factor: 3.402
Authors: Catherine E Lang; Dorothy F Edwards; Rebecca L Birkenmeier; Alexander W Dromerick Journal: Arch Phys Med Rehabil Date: 2008-09 Impact factor: 3.966
Authors: Albert Moraska; Robin A Pollini; Karen Boulanger; Marissa Z Brooks; Lesley Teitlebaum Journal: Evid Based Complement Alternat Med Date: 2008-05-07 Impact factor: 2.629